FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves a supplemental application for mycophenolate mofetil, the generic immunosuppressant, via Teva Pharmaceuticals USA, Inc. This action updates the pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation
• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)